David L. McClure, Ph.D. - Publications

Affiliations: 
2005 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Public Health

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Boyce TG, McClure DL, Hanson KE, Daley MF, DeSilva MB, Irving SA, Jackson LA, Klein NP, Lewin B, Williams JTB, Duffy J, McNeil MM, Weintraub ES, Belongia EA. Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiology and Drug Safety. 33: e5863. PMID 39155049 DOI: 10.1002/pds.5863  0.383
2024 Boyce TG, Levine MZ, McClure DL, King JP, Flannery B, Nguyen HQ, Belongia EA. Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human Vaccines & Immunotherapeutics. 20: 2370087. PMID 38982712 DOI: 10.1080/21645515.2024.2370087  0.379
2024 Malden DE, Liu IA, Qian L, Sy LS, Lewin BJ, Asamura DT, Ryan DS, Bezi C, Williams JTB, Kaiser R, Daley MF, Nelson JC, McClure DL, Zerbo O, Henninger ML, et al. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. Nature Communications. 15: 4101. PMID 38778026 DOI: 10.1038/s41467-024-48022-9  0.413
2024 Xu S, Sy LS, Hong V, Farrington P, Glenn SC, Ryan DS, Shirley AM, Lewin BJ, Tseng HF, Vazquez-Benitez G, Glanz JM, Fireman B, McClure DL, Hurley LP, Yu O, et al. Mortality risk after COVID-19 vaccination: A self-controlled case series study. Vaccine. PMID 38388239 DOI: 10.1016/j.vaccine.2024.02.032  0.325
2023 Katherine Yih W, Daley MF, Duffy J, Fireman B, McClure DL, Nelson JC, Qian L, Smith N, Vazquez-Benitez G, Weintraub E, Williams JTB, Xu S, Maro JC. Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink. Vaccine. PMID 37479610 DOI: 10.1016/j.vaccine.2023.07.010  0.382
2023 Petrie JG, King JP, McClure DL, Rolfes MA, Meece JK, Pattinson D, Neumann G, Kawaoka Y, Belongia EA, McLean HQ. Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza and Other Respiratory Viruses. 17: e13104. PMID 36875208 DOI: 10.1111/irv.13104  0.345
2022 Xu S, Huang R, Sy LS, Hong V, Glenn SC, Ryan DS, Morrissette K, Vazquez-Benitez G, Glanz JM, Klein NP, Fireman B, McClure D, Liles EG, Weintraub ES, Tseng HF, et al. A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. Vaccine. PMID 36564276 DOI: 10.1016/j.vaccine.2022.12.036  0.39
2022 Yih WK, Daley MF, Duffy J, Fireman B, McClure D, Nelson J, Qian L, Smith N, Vazquez-Benitez G, Weintraub E, Williams JTB, Xu S, Maro JC. A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink. Vaccine. PMID 36535825 DOI: 10.1016/j.vaccine.2022.12.026  0.401
2022 Katherine Yih W, Daley MF, Duffy J, Fireman B, McClure D, Nelson J, Qian L, Smith N, Vazquez-Benitez G, Weintraub E, Williams JTB, Xu S, Maro JC. Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink. Vaccine. PMID 36481108 DOI: 10.1016/j.vaccine.2022.11.053  0.371
2022 McLean HQ, McClure DL, King JP, Meece JK, Pattinson D, Neumann G, Kawaoka Y, Rolfes MA, Belongia EA. mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021. Influenza and Other Respiratory Viruses. PMID 35178857 DOI: 10.1111/irv.12970  0.363
2021 Glanz JM, Clarke CL, Daley MF, Shoup JA, Hambidge SJ, Williams JTB, Groom HC, Kharbanda EO, Klein NP, Jackson LA, Lewin BJ, McClure DL, Xu S, DeStefano F. The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 148. PMID 34851413 DOI: 10.1542/peds.2021-051910  0.317
2021 Xu S, Huang R, Sy LS, Glenn SC, Ryan DS, Morrissette K, Shay DK, Vazquez-Benitez G, Glanz JM, Klein NP, McClure D, Liles EG, Weintraub ES, Tseng HF, Qian L. COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1520-1524. PMID 34710075 DOI: 10.15585/mmwr.mm7043e2  0.386
2021 Naleway AL, Crane B, Irving SA, Bachman D, Vesco KK, Daley MF, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Klein NP, McCarthy NL, McClure DL, Panagiotakopoulos L, Panozzo CA, et al. Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. Therapeutic Advances in Drug Safety. 12: 20420986211021233. PMID 34178302 DOI: 10.1177/20420986211021233  0.352
2021 Naleway AL, Crane B, Irving SA, Bachman D, Vesco KK, Daley MF, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Klein NP, McCarthy NL, McClure DL, Panagiotakopoulos L, Panozzo CA, et al. Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. Therapeutic Advances in Drug Safety. 12: 20420986211021233. PMID 34178302 DOI: 10.1177/20420986211021233  0.352
2020 Panagiotakopoulos L, McCarthy NL, Tepper NK, Kharbanda EO, Lipkind HS, Vazquez-Benitez G, McClure DL, Greenberg V, Getahun D, Glanz JM, Naleway AL, Klein NP, Nelson JC, Weintraub ES. Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink. Obstetrics and Gynecology. PMID 33156197 DOI: 10.1097/AOG.0000000000004166  0.399
2020 Glanz JM, Clarke CL, Xu S, Daley MF, Shoup JA, Schroeder EB, Lewin BJ, McClure DL, Kharbanda E, Klein NP, DeStefano F. Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. Jama Pediatrics. PMID 32150236 DOI: 10.1001/Jamapediatrics.2019.6324  0.399
2019 Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, DeStefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, et al. Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. PMID 31740498 DOI: 10.1542/Peds.2019-1808  0.458
2019 Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, et al. Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15. Vaccine. PMID 31540812 DOI: 10.1016/J.Vaccine.2019.09.035  0.469
2018 McClure DL, Jacobsen SJ, Klein NP, Naleway AL, Kharbanda EO, Glanz JM, Jackson LA, Weintraub ES, McLean HQ. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders. Vaccine. PMID 30478005 DOI: 10.1016/J.Vaccine.2018.11.038  0.408
2018 Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. Jama. 319: 906-913. PMID 29509866 DOI: 10.1001/Jama.2018.0708  0.462
2018 Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES. Infant Hospitalizations and Mortality After Maternal Vaccination. Pediatrics. PMID 29463582 DOI: 10.1542/Peds.2017-3310  0.44
2017 McCarthy NL, Sukumaran L, Newcomer S, Glanz J, Daley MF, McClure D, Klein NP, Irving S, Jackson ML, Lewin B, Weintraub E. Patterns of childhood immunization and all-cause mortality. Vaccine. PMID 29061349 DOI: 10.1016/J.Vaccine.2017.10.034  0.354
2017 Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA. Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink. Vaccine. PMID 28888342 DOI: 10.1016/J.Vaccine.2017.08.086  0.488
2016 Simpson MD, Kieke BA, Sundaram ME, McClure DL, Meece JK, Sifakis F, Gasser RA, Belongia EA. Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons. Open Forum Infectious Diseases. 3: ofw081. PMID 27419158 DOI: 10.1093/Ofid/Ofw081  0.377
2015 Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children. Vaccine. PMID 26518400 DOI: 10.1016/J.Vaccine.2015.10.076  0.489
2015 Jackson ML, Jackson LA, Kieke B, McClure D, Gaglani M, Murthy K, Malosh R, Monto A, Zimmerman RK, Foppa IM, Flannery B, Thompson MG. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine. 33: 5181-7. PMID 26271827 DOI: 10.1016/J.Vaccine.2015.07.098  0.479
2015 Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine. 33: 246-51. PMID 24962752 DOI: 10.1016/J.Vaccine.2014.06.052  0.472
2014 McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, Belongia EA. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1375-85. PMID 25270645 DOI: 10.1093/Cid/Ciu680  0.472
2014 Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, Zeng C, Glanz J. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biometrical Journal. Biometrische Zeitschrift. 56: 513-25. PMID 24402780 DOI: 10.1002/Bimj.201300012  0.451
2014 Simpson M, Kieke B, Sundaram M, Mcclure D, Meece J, Sifakis F, Gasser R, Mclean H, Belongia E. 1132Seasonal Incidence of Medically Attended RSV and Influenza Illness in Children 6-59 Months Old Open Forum Infectious Diseases. 1: S336-S336. DOI: 10.1093/Ofid/Ofu052.840  0.356
2013 Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley MF. A mixed methods study of parental vaccine decision making and parent-provider trust. Academic Pediatrics. 13: 481-8. PMID 24011751 DOI: 10.1016/J.Acap.2013.05.030  0.37
2013 Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine. 31: 3894-8. PMID 23831326 DOI: 10.1016/J.Vaccine.2013.06.051  0.48
2013 Sundaram ME, McClure DL, VanWormer JJ, Friedrich TC, Meece JK, Belongia EA. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 789-93. PMID 23748138 DOI: 10.1093/Cid/Cit379  0.478
2013 Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. Jama Pediatrics. 167: 274-81. PMID 23338829 DOI: 10.1001/Jamapediatrics.2013.502  0.407
2013 Xu S, Hambidge SJ, McClure DL, Daley MF, Glanz JM. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Statistics in Medicine. 32: 3290-9. PMID 23303643 DOI: 10.1002/Sim.5733  0.477
2012 McClure DL, Xu S, Weintraub E, Glanz JM. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 30: 3986-91. PMID 22531555 DOI: 10.1016/J.Vaccine.2012.04.040  0.444
2012 O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 129: 248-55. PMID 22232308 DOI: 10.1542/Peds.2011-1111  0.465
2012 Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, Shoup JA, Narwaney K, Baggs J, Weintraub E, Gay C, Nordin JD, Baxter R, Jacobsen SJ, Irving S, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children Pediatrics. 129: e54-e59. PMID 22157132 DOI: 10.1542/Peds.2011-1294  0.494
2011 Hambidge SJ, Ross C, McClure D, Glanz J. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort. Vaccine. 29: 8179-81. PMID 21930176 DOI: 10.1016/J.Vaccine.2011.09.002  0.479
2011 Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, Glanz J. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Statistics in Medicine. 30: 742-52. PMID 21394750 DOI: 10.1002/Sim.4125  0.41
2011 Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 29: 994-9. PMID 21145372 DOI: 10.1016/J.Vaccine.2010.11.085  0.424
2010 Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ. Parental refusal of varicella vaccination and the associated risk of varicella infection in children. Archives of Pediatrics & Adolescent Medicine. 164: 66-70. PMID 20048244 DOI: 10.1001/Archpediatrics.2009.244  0.39
2009 Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Salmon DA, Hambidge SJ. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics. 123: 1446-51. PMID 19482753 DOI: 10.1542/Peds.2008-2150  0.408
2008 McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 26: 3341-5. PMID 18462849 DOI: 10.1016/J.Vaccine.2008.03.074  0.471
2007 McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. Journal of Clinical Epidemiology. 60: 812-8. PMID 17606177 DOI: 10.1016/J.Jclinepi.2006.11.006  0.47
2007 McClure DL, Valuck RJ, Glanz M, Hokanson JE. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiology and Drug Safety. 16: 132-43. PMID 17072896 DOI: 10.1002/Pds.1341  0.457
2006 France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, Shay D, Weintraub E, Fry AM, Black SB, Shinefield HR, Mullooly JP, Jackson LA. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Archives of Pediatrics & Adolescent Medicine. 160: 1277-83. PMID 17146026 DOI: 10.1001/Archpedi.160.12.1277  0.41
2006 Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Jama. 296: 1990-7. PMID 17062862 DOI: 10.1001/Jama.296.16.1990  0.456
2006 Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Journal of Clinical Epidemiology. 59: 808-18. PMID 16828674 DOI: 10.1016/J.Jclinepi.2005.11.012  0.439
Show low-probability matches.